Biotech

  1. Industry Sectors
  2. Biotech
Find Biotech companies London ads at NewsNow Classifieds/Jobs
Alzheimer’s drug failure leaves Biogen in a precarious place STAT17:11
Biogen value drops by $18bn after Alzheimer’s drug failure Biopharma Reporter17:20
Why Biogen Stock Is Crashing Today The Motley Fool14:42
WuXi PharmaTech subsidiaries hit regulatory and manufacturing milestone Manufacturing Chemist15:24
How to Build a Better Biotech Stock Portfolio The Motley Fool15:12
If you like AstraZeneca, you could love this health-focused small-cap Motley Fool (UK)15:02
Forma Therapeutics nabs long-time Genentech commercial executive as CEO FierceBiotech14:22
BREAKING: Biogen halts Alzheimer's drug trials in 'transformative' failure for the biotech BioPharma Dive13:36
Alexion signs R&D deals with two Nordic biotechs pharmaphorum12:16
Athenex Announces Xiangxue Life Sciences Receives IND Allowance from China’s National Medical Products Administration… GlobeNewswire12:34
Celgene signs $25m AI drug discovery partnership with Exscientia Pharmaceutical Technology12:33
Pfizer and Vivet Therapeutics to collaborate on Wilson disease therapy Pharmaceutical Technology12:23
Choose date and time: ×
In the last half-hour
Is Elizabeth Holmes's Deep Voice Just Another Part of Her Scam? Harper's Bazaar19:37
In the last hour
Aducanumab Failure: Selectivity for the Toxic Oligomer is Essential to Treating Root Cause of Alzheimer’s Disease GlobeNewswire19:17
BioTech Pharma Summit: 3rd Annual Biosimilars and Biologics: Global Biosimilars Require Regional Development Approaches Center for Biosimilars19:15
Biogen Tanks, Drags Down Biotechnology Sector ETFs ETF Trends19:10
AbbVie Donates $40 Million to Rebuild North Chicago Middle School PR Newswire (Press Release)19:01
In the last 2 hours
My mix-and-match career Science Magazine18:22
NE Ohio is third-largest region in U.S. for healthcare investments in 2018: BioEnterprise report Cleveland.com18:19
Health Care Sector Update for 03/21/2019: OGEN,NVCN,BIIB Nasdaq18:08
In the last 4 hours
Steve Tregay’s exit from Forma marked the end of a $757M collaboration with Celgene ENDPOINTS17:55
Biogen value drops by $18bn after Alzheimer’s drug failure Biopharma Reporter17:20
Alzheimer’s drug failure leaves Biogen in a precarious place STAT17:11
What Brexit Effect? UK Biotech Start-Ups Reach Record Numbers Scrip Pharma Intelligence16:49
BB BIOTECH AG: Shareholders at the general meeting vote in favor of all proposals and approve… DGAP16:47
Plans to boost Scotland’s ‘bio-revolution’ secure seed funding The Scotsman16:37
In the last 6 hours
Puma to pay PPD founder Eshelman $22M in defamation suit FiercePharma15:57
BioTech Pharma Summit: 3rd Annual Biosimilars and Biologics: Regulator Explains How Denmark Has Achieved Its Biosimilar … Center for Biosimilars15:33
WuXi PharmaTech subsidiaries hit regulatory and manufacturing milestone Manufacturing Chemist15:24
Founding Forma CEO Steve Tregay follows 61 staffers out the exit, replaced by Genentech strategy vet ENDPOINTS15:23
How to Build a Better Biotech Stock Portfolio The Motley Fool15:12
SK Biopharm gets approval for sleep disorder drug Korea JoongAng Daily15:06
If you like AstraZeneca, you could love this health-focused small-cap Motley Fool (UK)15:02
European ADRs Move Lower in Thursday Trading Nasdaq14:53
Biogen ends trial of Alzheimer's drug UPI14:47
Why Biogen Stock Is Crashing Today The Motley Fool14:42
Roivant's rare disease shop captures FDA designations; China biotech lands $18M launch round ENDPOINTS14:33
EuroBiotech Report—Alexion's Euro deals, Biogen-Nightstar, Genfit IPO and Allergy flop FierceBiotech14:32
Biotech builder Cydan boosts R&D leadership with 2 new hires FierceBiotech14:32
Forma Therapeutics nabs long-time Genentech commercial executive as CEO FierceBiotech14:22
UK biotech industry booms on record investment – analysis pharmaphorum14:17
Galera Therapeutics Announces Presentation of Data from Phase 2b Clinical Trial of Avasopasem Manganese at 2019 NCCN… GlobeNewswire14:15
Brexit who? Record investment last year fuels big spike in registered UK biotech firms ENDPOINTS14:13
Alexion strikes Zealand deal to further pipeline rebuild FierceBiotech14:12
In the last 8 hours
Biogen halted its Alzheimer's drug trial. Here's what that means for biotech investors CNBC13:58
Biotech company shares plummet after ending Alzheimer's drug trial The Independent13:57
Pfizer buys stake in French gene therapy company Vivet PharmaTimes13:57
Biotech growth in UK booms 65% since 2016 PharmaTimes13:57
Biogen shares tank nearly 30% after pulling key Alzheimer’s drug trial Yahoo! US13:54
BREAKING: Biogen halts Alzheimer's drug trials in 'transformative' failure for the biotech BioPharma Dive13:36
RegeneRx Announces New Board Member PR Newswire (Press Release)12:52
Opportunities For Biotech CompaniesMay Exist In The Anti-Aging Market Forbes12:50
Momenta Pharmaceuticals Announces Publication of New Data Supporting M281 as First Anti-FcRn Antibody to Inhibit… GlobeNewswire12:44
Athenex Announces Xiangxue Life Sciences Receives IND Allowance from China’s National Medical Products Administration… GlobeNewswire12:34
Celgene signs $25m AI drug discovery partnership with Exscientia Pharmaceutical Technology12:33
Curtain Pulled Back On Group Behind Deluge Of Public Comments Over HHS' Proposal To End Rebate System Kaiser Health News12:27
Pfizer and Vivet Therapeutics to collaborate on Wilson disease therapy Pharmaceutical Technology12:23
BioTech Pharma Summit: 3rd Annual Biosimilars and Biologics: More Than a Decade After the First Biosimilar, the… Center for Biosimilars12:21
InVitae Corp: This Biotech Stock Just Surged 120%, More to Come? Profit Confidential12:21
Biogen shares plunge after Alzheimer’s drug setback Boston Globe12:19
Number of biotechnology companies grows by two thirds over three years Growth Business12:17
Alexion signs R&D deals with two Nordic biotechs pharmaphorum12:16
AI drug R&D company Exscientia signs deal with Celgene pharmaphorum12:16
Billionaire Bertarelli's Waypoint steers allergy drugmaker Stallergenes Greer private in $832M buyout deal ENDPOINTS12:12
BioLineRx to Report Annual 2018 Results on March 28, 2019 PR Newswire (Press Release)12:12
Teva Selects Genedata Biologics to Support Next-generation Biopharmaceuticals R&D PRWeb (Press Release)12:12
Celgene taps Exscientia’s AI drug discovery tech for 3 new programs FierceBiotech12:11
Earlier today
Proxy Advisors Could Tilt the Scales in the Bristol-Celgene Deal. Watch for Their Calls Next Week. Barron's Online11:50
Celgene inks drug discovery deal worth at least £25m with AI firm Exscientia Pharmafile11:46
Biogen halts studies of closely watched Alzheimer’s drug, a blow to hopes for new treatment STAT11:40
Amgen, Servier heart failure drug clears trial hurdle PMLiVE10:58
Faster, cheaper, better? Post-buyout deal Celgene jumps into AI alliance with a $25 million bet on speeding discovery… ENDPOINTS10:51
Frontier IP upgrades full year forecasts as portfolio firm Exscientia inks deal with biotech… Proactive Investors (UK)10:45
Celgene partners with AI drug discovery startup to make drug trials shorter Verdict10:20
Merck extends research alliance with NGM Bio Pharmaceutical Technology10:12
FITCI Success Story: NanoBioFab Pitches at MedTech Innovator Event PRWeb (Press Release)10:11
Celgene & Exscientia in AI drug discovery collaboration Pharmaceutical Field09:51
UK biotech industry hits 65% growth Manufacturing Chemist09:11
Pfizer buys stake in liver gene therapy player Vivet European Biotechnology News08:39
Marinomed Biotech AG (MARI-AT): Solving the insoluble DGAP08:19
Scancell Holdings Plc Professor Lindy Durrant receives Waldenström award ADVFN07:51
Pfizer secures exclusive option to acquire gene therapy company Vivet Therapeutics Science|Business07:27
Dr. Martin Edwards Joins Verona Pharma as Non-Executive Director GlobeNewswire07:02
Pharma MNCs wary of illegal import of innovator drugs The Times of India06:26
Probiodrug AG: Probiodrug AG to Publish its Full Year 2018 Results on March 28, 2019 DGAP06:07
Pfizer makes sure it won't get left out of the gene therapy deal boom BioPharma Dive03:51
SK Biopharmaceuticals marks first FDA approval The Korea Herald03:12
APRIL 23 DEADLINE: Pawar Law Group Announces a Securities Class Action Lawsuit Against Amarin Corporation plc – AMRN GlobeNewswire00:59
Pfizer secures option to acquire Vivet for up to $635.8m Biopharma Reporter00:34
Yesterday
MatriSys Bioscience announces successful FDA Pre-IND review and Phase 2 plans for MSB-01, a revolutionary… GlobeNewswire23:59 20-Mar-19
5 Notable Stocks Insiders Are Selling Seeking Alpha23:33 20-Mar-19
Celgene Presents An Attractive Short-Term Investment Opportunity In March 2019 Seeking Alpha23:33 20-Mar-19
Biotech Analysis Central Pharma News: AbbVie's Trouble, Merck KGaA's Bad Streak, Puma's Positive Data Seeking Alpha23:33 20-Mar-19
Innovent Announces First Patient Dosed in a Phase IIa Clinical Study of IBI306, an Anti-PCSK9… PR Newswire (Press Release)23:30 20-Mar-19
The global downstream processing market size is expected to reach USD 39.37 billion by 2025 PR Newswire (Press Release)22:15 20-Mar-19
Here's Why Cytokinetics Stock Jumped Today The Motley Fool20:54 20-Mar-19
Why Pfizer Is Getting Deeper Into Gene Therapy 24/7 Wall St.20:28 20-Mar-19
Dynavax to Present on Inhaled TLR9 Agonist DV281 at the AACR Annual Meeting 2019 GlobeNewswire20:27 20-Mar-19
Indian brothers wanted for defrauding $725 mln, were building apartments in Tirana as Albanian… Top Channel20:18 20-Mar-19
China is Cloning Police Dogs Now Nerdist20:16 20-Mar-19
BriaCell Announces $2,000,000 Non-Brokered Private Placement Offering GlobeNewswire20:07 20-Mar-19
China says they've cloned the 'Sherlock Holmes' of police dogs New York Post18:57 20-Mar-19
What Investors Are Missing About AbbVie Seeking Alpha17:31 20-Mar-19
Quantum Genomics Announces Positive Results from New Preclinical Studies on Firibastat GlobeNewswire17:05 20-Mar-19
AbbVie is sued for using Humira patent deals to block competition in the U.S. STAT16:44 20-Mar-19
Eloxx Pharmaceuticals to Present at the Guggenheim Rare Disease & Genomic Medicines Day on April 2, 2019 GlobeNewswire16:25 20-Mar-19
3SBio Unveils 2018 Annual Results: Revenue Soars by 22.7%, Normalized Net Profit Soars by… PR Newswire (Press Release)16:19 20-Mar-19
AbbVie sued by New York grocery union over Humira defense FiercePharma16:18 20-Mar-19
Why Novavax Is Soaring Today The Motley Fool16:02 20-Mar-19
Flagship Pioneering raises $824m in VC round, its most ever Boston Globe15:42 20-Mar-19
Flagship Pioneering raises $824 million in venture capital round, its most ever STAT15:42 20-Mar-19
Without 'smoking gun,' BMS, Celgene deal will close: analyst FiercePharma15:27 20-Mar-19
Flagship Pioneering adds a new $824M biotech growth fund FierceBiotech15:23 20-Mar-19
European ADRs Move Lower in Wednesday Trading Nasdaq14:50 20-Mar-19
AbbVie, Roche stop recruiting in Venclexta's myeloma trials FiercePharma14:47 20-Mar-19

NewsNow Classifieds » Jobs » Top Searches

view more
© Copyright 1997 - 2019 NewsNow Publishing Limited. All rights reserved.

No account? Sign up!

  • Bookmark your favourite topics and create your very own NewsNow page.
  • Save publication preferences and your reading history for quick reference.
  • Take this with you whenever and wherever you sign in!
Site View
Publication filters

Headline Density

  • By clicking "OK" or continuing to use this site, you agree that we may collect and use your personal data and set cookies to improve your experience and customise advertising. To see how, and to learn how to control cookies, please read our Privacy Policy and Cookie Policy.
Sorry, no headlines or news topics were found. Please try different keywords.
Rest of site